|
|
Lijuan Pang, Ph.D. The Scripps Research Institute 10550 North Torrey Pines Road, MB-209 La Jolla, CA 92037 858-784-9683(phone) 858-784-9690 (FAX) lpang@scripps.edu |
 |
EDUCATION: April 2014 - Ph.D. Medicinal Chemistry, University of Basel, Basel (Switzerland) 2008 - M.Sc. Chemical Biology, Peking University, Beijing (China) 2005 - B.Sc. Pharmacy, Peking University, Beijing (China) PROFESSIONAL EXPERIENCES: June 2014 to Present: Research Associate @ The Scripps Research Institute, La Jolla, CA, USA (Advisor: Prof. James C. Paulson) 2010 to 2014: PhD Student, University of Basel, Basel, Switzerland (Advisor: Dr. Beat Ernst) 2010 to 2013: Assistant of Practical Course, Pharm. Chem. II CombiChem (for the last-year bachelor students), Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland 2011: Tutor of master thesis, Institute of Molecular Pharmacy, University of Basel, Basel, Switzerland 2009 to 2010: R&D Chemist II of drug discovery and development, Bioduro (Beijing) Inc., Beijing, China 2008 to 2009: R&D Assistant Researcher of organic process research & development, Apotex Pharmachem (Tianjin) Inc., Tianjin, China AWARDS: 2014: Scholarship Early Postdoc, Swiss National Science Foundation 2011: Awarded Travel Fund for Young Academics, University of Basel 2009: Top 5% score in Annual Assessment of Working Performance, Apotex Pharmachem Inc. 2005: Scholarship for Outstanding Medical Students, Ministry of Public Health of China 2002 to 2005: Prize of Annual Outstanding Medical Students, Peking University 2002 to 2005: Scholarship for Outstanding Medical Students, Peking University PUBLICATIONS: Pang L, Macauley MS, Arlian BM, Nycholat CM, Paulson JC. Encapsulating An Immunosuppressant Enhances Tolerance Induction by Siglec Engaging Tolerogenic Liposomes. Chembiochem. 2017;18(13):1226-1233. Kleeb S, Pang L, Mayer K, Eris D, Sigl A, Preston RC, Zihlmann P, Sharpe T, Jakob RP, Abgottspon D, Hutter AS, Scharenberg M, Jiang X, Navarra G, Rabbani S, Smiesko M, Ludin N, Bezencon J, Schwardt O, Maier T, Ernst B. FimH Antagonists: Bioisosteres To Improve the in Vitro and in Vivo PK/PD Profile. J Med Chem. 2015;58(5):2221-39. Scharenberg M, Jiang X, Pang L, Navarra G, Rabbani S, Binder F, et al. Kinetic properties of carbohydrate-lectin interactions: FimH antagonists. ChemMedChem. 2014;9(1):78-83. Pang L, Kleeb S, Lemme K, Rabbani S, Scharenberg M, Zalewski A, et al. FimH antagonists: structure-activity and structure-property relationships for biphenyl alpha-D-mannopyranosides. ChemMedChem. 2012;7(8):1404-22. Klein T, Abgottspon D, Wittwer M, Rabbani S, Herold J, Jiang X, et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J Med Chem. 2010;53(24):8627-41. Pang LJ, Wang D, Zhou J, Zhang LH, Ye XS. Synthesis of neamine-derived pseudodisaccharides by stereo- and regio-selective functional group transformations. Org Biomol Chem. 2009;7(20):4252-66. |
| HOME | RESEARCH | PUBLICATIONS | GROUP MEMBERS | OTHER RESOURCES |